Cargando…
Local Release of TGF‐β Inhibitor Modulates Tumor‐Associated Neutrophils and Enhances Pancreatic Cancer Response to Combined Irreversible Electroporation and Immunotherapy
Pancreatic cancer is a deadly disease with little response to standard therapies. Irreversible electroporation (IRE) has emerged as a novel ablative technique for the clinical treatment of pancreatic cancer. Combinations of IRE and immunotherapies, including anti‐programmed death 1 (αPD1) immune che...
Autores principales: | Peng, Huiming, Shen, Jian, Long, Xin, Zhou, Xiaoqi, Zhang, Jiaqi, Xu, Xina, Huang, Teng, Xu, Hui, Sun, Shuguo, Li, Chun, Lei, Ping, Wu, Heshui, Zhao, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981446/ https://www.ncbi.nlm.nih.gov/pubmed/35128843 http://dx.doi.org/10.1002/advs.202105240 |
Ejemplares similares
-
Safety and Efficacy of Irreversible Electroporation in Locally Advanced Pancreatic Cancer: An Evaluation from a Surgeon’s Perspective
por: Shen, Jian, et al.
Publicado: (2022) -
Sequential Irreversible Electroporation for Locally Advanced Pancreatic Cancer
por: Ong, Daniel Yuxuan, et al.
Publicado: (2023) -
Case report: Irreversible electroporation for locally advanced pancreatic cancer
por: Orcutt, Sonia, et al.
Publicado: (2017) -
Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2021) -
Immunomodulatory Effect of Irreversible Electroporation Alone and Its Cooperating With Immunotherapy in Pancreatic Cancer
por: Tian, Guo, et al.
Publicado: (2021)